Download PDF
Methods Inf Med 1998; 37(02): 182-187
DOI: 10.1055/s-0038-1634518
Original Article
Schattauer GmbH

Periodical Multiphasic Screening and Lung Cancer Prevention

R. S. Carel
1   Dept of Occupational Medicine, Division of Community Health, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel and the MOR Institute for Medical Data, IsraeL
› Author Affiliations
Further Information

Publication History

Publication Date:
07 February 2018 (online)

    Permissions and Reprints

Abstract

The purpose of this work is to evaluate the utilization of information gathered by multiphasic screening with respect to lung cancer detection and smoking cessation techniques. A cohort (follow-up) study is reported in which cancer incidence and factors affecting its occurrence are evaluated in a group of about 20,000 presumably healthy adults along a period of approximately 10 years following comprehensive multiphasic health examinations. Lung cancer occurrence is primarily related to smoking. The risk is higher in smokers and is dose-dependent; OR = 0.21, (CI = 0.08,.53) in never smokers, OR = 1.53 (CI = 0.8,3.2) in past and current moderate smokers, OR = 4.92 (CI = 2.18,11.11) in current heavy smokers. Moreover, smokers with compromised pulmonary function (FEVI/FVC < 75%) are at an even higher risk of developing lung cancer OR = 4.22 (CI = 2.2, 8.2) for past and current moderate smokers; and OR = 10.7 (CI-2.5, 38.6) in current heavy smokers. Information gathered in periodical multiphasic health examinations could be utilized by health professionals to encourage smoking cessation and smoking prevention in the appropriate screenees. Various elements of the multiphasic test results could contribute to such prevention efforts. While every smoker should receive appropriate evaluation and consultation regarding nicotine dependence, smokers with reduced pulmonary function represent an extra high risk group to which special attention should be given.

Keywords

Multiphasic Screening - Lung Cancer - Smoking - Logistic Regression
 

  • REFERENCES

  • 1 Collen MF. ed. Multiphasic Health Testing Services. New York: John Wiley and Sons; 1978
    Google Scholar
  • 2 Friedman GD, Collen MF, Fireman BH. Multiphasic health checkup evaluation: A 16-year follow-up. J Chron Dis 1986; 39: 453-63.
    CrossrefPubMedGoogle Scholar
  • 3 Prinkeston PE, Jackson MG, Yankaskas BC, Berger A. Preemployment multiphasic screening in an urban manpower training program. J Occup Med 1983; 25: 112-4.
    PubMedGoogle Scholar
  • 4 Report of the US Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins; 1989
    Google Scholar
  • 5 Canadian Task Force on the Periodic Health Examination: The periodic health examination. 1958 update. Can Med Assoc J 1988; 138: 617-26.
    PubMedGoogle Scholar
  • 6 Wingo PA, Tong T, Bolden S. Cancer Statistics, 1995. CA: 1995. 45 8-30.
    Google Scholar
  • 7 Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA. ed. Cancer Principles and Practice of Oncology, 4th ed.. Philadelphia: JB Lippincott Co; 1993: 673-5.
    Google Scholar
  • 8 Ginsberg RL. Limited resection in the treatment of stage I non-small cell lung cancer: An overview. Chest 1989; 96 (Suppl) 505-15.
    CrossrefPubMedGoogle Scholar
  • 9 Melamed MR, Fleliinger BJ, Zaman MB. et al Screening for early cancer: Results of the Memorial Sioan-Kettering study in New York. Chest 1984; 86: 44-53.
    CrossrefPubMedGoogle Scholar
  • 10 The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Summary and conclusions. Am Rev Respir Dis 1984; 130: 565-7.
    PubMedGoogle Scholar
  • 11 Fontana RS, Sanderson DR, Woolner LB. et al Lung cancer screening: The Mayo Program. J Occup Med 1986; 28: 746-50.
    CrossrefPubMedGoogle Scholar
  • 12 Tockman MS, Frost JK, Stitik FP. et al Screening and detection of lung cancer. In: Aisner J. ed. Lung Cancer. New York: Churchill Livingston; 1985. pp 25-10.
    Google Scholar
  • 13 Kubik A, Polak J. Lung cancer detection: Results of a randomized prospective study in Czechoslovakia. Cancer 1986; 57: 2427-37.
    CrossrefPubMedGoogle Scholar
  • 14 Loeb LA, Ernsher VL, Abbots J, Lazlo J. Smoking and lung cancer: An overview. Cancer Res 1984; 44: 5940-58.
    PubMedGoogle Scholar
  • 15 Cullen JW. The National Cancer Institutes' smoking, tobacco and cancer program. Chest 1989; 96 (Suppl) 9-13.
    CrossrefPubMedGoogle Scholar
  • 16 Department of Health and Human Services: The health consequences of smoking: 25 years of progress. A report of the Surgeon General. Rockville Md.: Department of Health and Human Services; 1989. (Publication No DHHS (PHS) 89-8411.).
    Google Scholar
  • 17 Fielding JE. Smoking: health effects and control. New Engl J Med 1985; 313: 491-8.
    CrossrefPubMedGoogle Scholar
  • 18 Siemiatycki J, Krewshi D, Franco E, Kaisman M. Association between cigarette smoking and each of 21 types of cancer: A multi-site case-control study. Int J Epidemiology 1995; 24: 504-14.
    CrossrefPubMedGoogle Scholar
  • 19 American Cancer Society. Guidelines for the cancer-related check-up. CA: 1980. 30 199-207.
    Google Scholar
  • 20 American College of Radiology. Policy statement: referral criteria for chest X-ray examinations. Chicago, 111.: American College of Radiology; 1982
    Google Scholar
  • 21 Morrison B. Lung cancer: Report for the Canadian Task Force on Periodic Health Examinations. Can Med Assoc J 1989; 134: 727-9.
    PubMedGoogle Scholar
  • 22 US Department of Health and Human Services. Reducing the Health Benefits of Smoking Cessation. A Report of the Surgeon General. US Dept. of Health and Human Services. Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health. DHHS publication no (CDC) 90-8416 1990
    PubMedGoogle Scholar
  • 23 Lubin JH, Blot WJ. Lung cancer and smoking cessation: Patterns of risk. J Natl Cancer Inst 1993; 85: 422-3.
    CrossrefPubMedGoogle Scholar
  • 24 Phillips CJ, Prowle MJ. Economics of a reduction in smoking: Case study from Heartbeat Wales. J. Epidemiol Comm Health 1993; 47: 215-23.
    CrossrefPubMedGoogle Scholar
  • 25 Carel RS, Lleshem G. Evaluation of cost-effectiveness of an automated multiphasic health testing system. Prev Med 1980; 9: 689-97.
    CrossrefPubMedGoogle Scholar
  • 26 Carel RS, Kahan E, Hart Y, Panush N. Utilization of an automated multiphasic health testing system for performing pre-hospitalization examinations. Med Care 1982; 20: 871-5.
    CrossrefPubMedGoogle Scholar
  • 27 Carel RS, Evyatar J. Factors affecting leukocyte count in healthy adults. Prev Med 1985; 14: 607-19.
    CrossrefPubMedGoogle Scholar
  • 28 Carel RS. Findings in pre-employment examinations. Isr J Med Sei 1992; 28: 666-74.
    PubMedGoogle Scholar
  • 29 Magdison J. The chaid approach to segmentation modeling. In: Bagozzi R. (ed) Handbook of Marketing Research. Blackwell Publishers; Cambridge, MA: 1993
    Google Scholar
  • 30 Kleinbaum DK, Kupper LL, Morgenstern H. Epidemiologic Research. Belmont, CA: Lifetime Learning Publication; 1982
    Google Scholar
  • 31 IARC Monographs on Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38. Tobacco Smoking. Lyon: IARG; 1986
    Google Scholar
  • 32 Kabat GC, Wynder EL. Determinants of quitting smoking. Am J Public Health 1987; 77: 1301-5.
    CrossrefPubMedGoogle Scholar
  • 33 US Department of Health and Human Services: Strategies to Control Tobacco use in the United States: A Blueprint for Public Health Action in the 1990's. US Department of Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute. NIH Publication No. 92-3316 1991
    PubMedGoogle Scholar
  • 34 From the Centers for Disease Control and Prevention: Trends in smoking initiation among adolescents and young adults-United States, 1980-1989. JAMA 1995; 274: 528-9.
    CrossrefPubMedGoogle Scholar
  • 35 Menck HR, Garfinkel L, Dodd GD. Preliminary report of the National Cancer Data Base. CA: 1991. 41 7-18.
    Google Scholar
  • 36 Schwartz JL. Review and Evaluation of Smoking Cessation Methods. The United States and Canada, 1978-1985. Bethesda, MD: Division of Cancer Prevention and Control, National Cancer Institute; 1987. NIH Publication no. 87-2940.
    Google Scholar
  • 37 Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Nat Cancer Inst 1993; 85: 457-64.
    CrossrefPubMedGoogle Scholar
  • 38 Weiss ST, Segal MR, Sparrow D, Wager C. Relation of FEVI and peripheral blood leukocyte count to total mortality. Am J Epidemiol 1995; 142: 493-8.
    CrossrefPubMedGoogle Scholar
  • 39 Dawber TR. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Harvard University Press; Cambridge, MA: 1980. Chapter 11. Tobacco and Cardiovascular Disease..
    Google Scholar
  • 40 Blum A. Curtailing the tobacco pandemic. In: De Vita VT, Hellman S, Rosenberg SA. (eds) Cancer principles and practice of Oncology. J.B. Lippincott Co; Philadelphia: 1993. Chapter 6, pp 480-91.
    Google Scholar
  • 41 Anstoker J. Cancer prevention in primary care: Current trends and prospects for the future. Br Med J 1994; 309: 449-52.
    CrossrefPubMedGoogle Scholar
  • 42 Skillurd DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. Ann Intern Med 1986; 105: 503-7.
    CrossrefPubMedGoogle Scholar
  • 43 Kuller LH, Ockene J, Heilahn E, Svendsen KH. Relation of forced expiratory volume in one second (FEVI) to lung cancer mortality in the multiple risk factor intervention trial (MRFIT). Am J Epidemiol 1990; 132: 265-74.
    CrossrefPubMedGoogle Scholar
  • 44 Tockman MS, Anthonisen NR, Wright EC. et al Airways obstruction and the risk for lung cancer. Ann Intern Med 1987; 106: 512-8.
    CrossrefPubMedGoogle Scholar
  • 45 Carta P, Cocco P. Picchiri Gianfranco: Lung cancer mortality and airways obstruction among metal miners exposed to silica and low levels of radon daughters. Am J Indust Medicine 1994; 25: 489-506.
    PubMedGoogle Scholar
  • 46 Lange P, Nyobe J, Appleyard M, et al. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis 1990; 141: 613-617.
    CrossrefPubMedGoogle Scholar